:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Mamoor, Shahan
Format:	Recurso digital
Language:
Published:	Zenodo 2025
Online Access:	https://doi.org/10.5281/zenodo.14676055
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ECT2 is a sensitive and specific marker of transformation in the human breast.
by: Mamoor, Shahan
Published: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)

Gasdermin activation during lineage specification in the human embryo.
by: Mamoor, Shahan
Published: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025)

SSX2IP induction in basal subtype breast cancer.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
by: Mamoor, Shahan
Published: (2025)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
by: Mamoor, Shahan
Published: (2026)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
by: Mamoor, Shahan
Published: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
by: Mamoor, Shahan
Published: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
by: Mamoor, Shahan
Published: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
by: Mamoor, Shahan
Published: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
by: Mamoor, Shahan
Published: (2026)

Developmental stage-specific control of proliferation and senescence by EZH2.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
by: Mamoor, Shahan
Published: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)

Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)